Table 4

Mean homocysteine concentration at follow up* according to treatment group and fracture outcomes
With fracture mean (standard deviation) Without fracture mean (standard deviation) Difference, (95% confidence interval) P-value (paired t-test)
Homocysteine (micromol/L
Placebo (n = 584) 15.7 (5.9) (n = 23) 14.2 (6.1) (n = 561) −1.52 (−4.08,1.04) 0.2447
B-Vitamins (n =580) 11.7 (9.6) (n = 18) 10.5 (4.6) (n = 562) −1.17 (−3.46,1.11) 0.3118

* The difference between baseline and follow-up Homocysteine levels were also compared between patients with and without facture. The differences are not significant, either (data not shown).

Note: Only a small subset of patients (14.3%) had homocysteine levels measured at final follow up.

Gommans et al.

Gommans et al. BMC Geriatrics 2013 13:88   doi:10.1186/1471-2318-13-88

Open Data